Honored to have been part of this project. Thanks to @1969carodriguez for the opportunity. Congratulations to Francesco Schettini, Giuseppe Di Grazia and all co-authors for this great publication in European Journal of Cancer!
PROUDER-BC study published. Congrats and thanks to F.Schettini, @dmorchon95 et al.
- Prosigna can identify young women candidate to chemotherapy, just like OncotypeDX or Mammaprint.
- The study has been published right before #ASCO2026 and OPTIMA trial!
https://t.co/LRIqX5oZnw
Preclinical findings show antitumour activity of triple #KRAS inhibition in mouse models, but it will take years of rigorous research to assess its clinical efficacy in oncology patients. Read more in the #ESMODailyReporter👉 https://t.co/2BuhWSWNCn
@rachnatshroff@BenWestphalen
📊 💻 🧠
Puede ChatGPT sustituir a un comité de Oncólogos expertos en la toma de decisiones en Cáncer de Mama precoz⁉️
El Dr @dmorchon95 presenta los resultados del trabajo del Hospital Univ. de Salamanca @Salud_JCYL en #SEOM25#somosCAUSA
Thanks for the mention @CataniGreta! A true pleasure working with you under the expert guidance of @AhernandoCalvo and the rest of the @VHIO team. Thrilled to share our review on biomarkers in early-phase immunotherapy trials!
Our review on biomarker enrichment in early-phase immunotherapy trials is out in @FrontiersIn
Grateful to collaborate with @dmorchon95 and especially for the mentorship and guidance of @AhernandoCalvo, who made this work possible
https://t.co/ca26OBMdy7
Just published 🗞️
Excited to share our latest research on mBC and PIK3CA mutations in tissue and plasma 🧬
Crucial role of PIK3CA analysis in ctDNA 🕵🏼♂️
Special thanks to my mentors 🙇🏽♂️ @1969carodriguez@rebecaLozMe@IBSAL_IIS#PIK3CAteam
Key points ⤵️🧵 https://t.co/6BMl78X7ft
📣Muy orgullosa de anunciar el I Congreso ACLO de Tumores Digestivos que se celebrará el 15-16 de marzo en Valladolid.
📌 Con el aval de @_SEOM
📝Inscríbete, aún estás a tiempo https://t.co/uzQhdhLleh
No se puede pedir más. Increíble equipo el que ha representado al Servicio de Oncología del Hospital Universitario de Salamanca en #SEOM23
Orgulloso de tod@s vosotr@s 👏🏻👏🏻👏🏻 🩺🧬🥼🧪
Excelente presentación del Dr. Daniel Morchón del Complejo Asistencial Universitario de Salamanca de su comunicación oral sobre 14 años de experiencia del manejo y tratamiento de tumores germinales. #SEOM22@_SEOM
Dos de nuestros antiguos alumnos han conseguido su sueño. Después de su carrera de medicina, ahora son R1; Helena Alarcón en cardiología en Santander y Daniel Morchón en oncología en Salamanca. Nos sentimos muy orgullosos de vosotros. #Imagina#MiraMásAllá
I recently invited a first year med student to quiz me with the flashcards he was studying for his test....
I quickly regretted that decision👇
My new article is out @Medscape, reflecting on what it means to train good physicians
https://t.co/l4qSubAJLU